The ability to gain market access and strengthen relationships with payers is a top priority in today’s environment
Boston (PRWEB) March 25, 2015
National recruitment firm Slone Partners is pleased to announce the placement of Michael Hoffman as Director of National Accounts at Metamark Genetics.
At Metamark, Mr. Hoffman will develop and execute the strategic and tactical initiatives to secure and support payers, both regional and national.
“The ability to gain market access and strengthen relationships with payers is a top priority in today’s environment,” said Metamark CEO Shawn Marcell. “I am proud to announce the addition of Michael Hoffman to the Metamark team. With his expertise in market access and payer relations, Metamark will continue to lead innovation in prostate cancer and aid patients and healthcare professionals in making important decisions about treatment.”
Mr. Hoffman brings 15 years of successful market access strategies and healthcare trending insights in the diagnostics, genetic, personalized medicine, pharmaceutical, and biotech industries, most recently as Senior Director of Managed Care at Courtagen Life Sciences.
At Courtagen, Mr. Hoffman managed commercial and government accounts for the company’s genetic diagnostics book of business, interfacing with payers’ diagnostic leaders and pharmacy leaders to broaden business in the pharmacogenomics and personal medicine arenas.
Prior to Courtagen, Mr. Hoffman was Senior Director of Managed Care at Transgenomic Health / PGx Health, where he was the lead for all managed market strategies and tactics.
Metamark is a privately held company dedicated to improving cancer care by providing the next generation of diagnostic and prognostic testing. The company is advancing its contribution to oncology through its proprietary genomics and proteomics discovery platforms, a growing clinical research effort, and corporate alliances. Metamark has assembled a unique portfolio of testing services and products to inform critical decisions at each step of the care pathway in prostate cancer. The company’s interests also include bladder, colon, and breast cancers. For more information, please visit the Metamark website at http://www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark.
About Slone Partners
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for the diagnostics, life science tools, healthcare information technology, and laboratory testing industries. Slone Partners has offices in Boston, New York, Washington, D.C., and San Francisco.
For more information on Slone Partners placements, please visit http://www.slonepartners.com.